[Therapeutic innovations in chronic inflammatory bowel diseases with "biological therapy"--anti-TNF and more].
Schölmerich
J
J
Klinik und Poliklinik für Innere Medizin I, Klinikum der Universität Regensburg, 93042 Regensburg.
D003093:Colitis, Ulcerative / Q000188:drug therapy* / Q000276:immunology; D003424:Crohn Disease / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007375:Interleukin-1 / Q000037:antagonists & inhibitors; D008213:Lymphocyte Activation / Q000187:drug effects / Q000276:immunology; D016376:Oligonucleotides, Antisense / Q000627:therapeutic use*; D019936:Probiotics / Q000627:therapeutic use; D011994:Recombinant Proteins / Q000627:therapeutic use; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D007166:Immunosuppressive Agents; D007375:Interleukin-1; D016376:Oligonucleotides, Antisense; D011994:Recombinant Proteins; D014409:Tumor Necrosis Factor-alpha